[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341833-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-341833-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","observational-study-of-men-and-women-with-breast-cancer-in-terms-of-overall-survival-research-findings-summary","Observational Study of Men and Women with Breast Cancer in Terms of Overall Survival - Research Findings Summary","","This retrospective cohort study analyzes overall survival in breast cancer patients by sex, comparing 19 men and 2143 women among 2162 cases collected from 1 January 2010 to 31 December 2021. Breast cancer mortality patterns show that men constitute less than 1% of cases, yet clinical and prognostic questions remain. Kaplan–Meier estimates indicate 3-year overall survival of 91.1% for women versus 88.9% for men, with a log-rank test showing a statistically significant difference (p=0.009).",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/observational-study-of-men-and-women-with-breast-cancer-in-terms-of-overall-survival-research-findings-summary/341833/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/observational-study-of-men-and-women-with-breast-cancer-in-terms-of-overall-survival-research-findings-summary/341833.png","ImageObject",300,407,{"name":42,"@type":43},"Miles","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study’s main objective?","Question",{"text":63,"@type":64},"To compare survival outcomes between male and female breast cancer patients and assess differences in overall survival.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How many patients were included, and what years were covered?",{"text":68,"@type":64},"The study included 2162 cases (19 males and 2143 females) registered from 1 January 2010 to 31 December 2021.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the Kaplan–Meier analysis show for 3-year overall survival?",{"text":72,"@type":64},"The estimated 3-year overall survival was 91.1% for women and 88.9% for men.",{"name":74,"@type":61,"acceptedAnswer":75},"Were survival differences statistically significant?",{"text":76,"@type":64},"Yes. The log-rank test indicated a statistically significant difference in survival times between the groups (p=0.009), while the age-matched analysis yielded p=0.068.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},341833,1790527973,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":33,"preview_urls":150},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","cancers   \nArticle  \nObservational Study of Men and Women with Breast Cancer in Terms of Overall Survival  \nVlad Bogdan Varzaru 1,2,3, Diana-Maria Anastasiu-Popov 3, Anca-Elena Eftenoiu 4, Roxana Popescu 2,5, *, Daliborca Cristina Vlad 6, Cristian Sebastian Vlad 6, Aurica Elisabeta Moatar 2,7, Daniela Puscasiu 5 and Ionut Marcel Cobec 2,8  \nCitation: Varzaru, V.B.; AnastasiuPopov, D.-M.; Eftenoiu, A.-E.;  \nPopescu, R.; Vlad, D.C.; Vlad, C.S.; Moatar, A.E.; Puscasiu, D.; Cobec, I.M. Observational Study of Men and Women with Breast Cancer in Terms of Overall Survival. Cancers 2024, 16, 3049. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)cancers16173049  \nAcademic Editor: David Wong  \nReceived: 15 July 2024  \nRevised: 29 August 2024  \nAccepted: 30 August 2024  \nPublished: 1 September 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Doctoral School, Faculty of Medicine,“Victor Babes” University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania  \n2 ANAPATMOL Research Center, Faculty of Medicine,“Victor Babes” University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania  \n3 Clinic of Obstetrics and Gynecology, Diakoneo Diak Klinikum, 74523 Schwäbisch Hall, Germany  \n4 Department of Medical Genetics,“Carol Davila” University of Medicine and Pharmacy,  \n014461 Bucharest, Romania  \n5 Department of Cell and Molecular Biology,“Victor Babes” University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania  \n6 Department of Pharmacology,“Victor Babes” University of Medicine and Pharmacy Timisoara,  \n300041 Timisoara, Romania  \n7 Clinic of Internal Medicine-Cardiology, Klinikum Freudenstadt, 72250 Freudenstadt, Germany  \n8 Clinic of Obstetrics and Gynecology, Klinikum Freudenstadt, 72250 Freudenstadt, Germany  \n* Correspondence: popescu.roxana@umft.ro; Tel.:+40-723649886  \nSimple Summary: Breast cancer is the most common cancer and the leading cause of cancer-related deaths among women globally, with over 2.26 million new cases in women in 2020 . Male breast cancer, while rare (less than 1% of cases), is treated similarly to female breast cancer despite some clinical differences. Advances in treatment, such as using genomic and immunohistochemical markers, have significantly improved survival rates for women. Men with breast cancer are often older at diagnosis, and their prognosis may differ due to age and other factors. The survival analysis conducted on 2162 patients (19 males and 2143 females) suggests that male breast cancer may have a poorer prognosis compared to female breast cancer.  \nAbstract: Breast cancer is one of the most common cancers and the leading cause of cancer death in women. Less than 1% of breast cancer cases are male breast cancers. Although there has been significant progress made in the management of breast cancer, due to its rarity among men, the question of whether men and women with breast cancer have the same treatment response and survival rate still needs to be answered. The primary goal of this study is to compare survival outcomes between male and female breast cancer patients. Material and Method: This cohort study represents a retrospective and anonymized data analysis of 2162 breast cancer cases (19 males and 2143 females), registered over a period of 12 years, from 1 January 2010 to 31 December 2021, in the Clinic of Obstetrics and Gynecology, Diakoneo Diak Klinikum Schwäbisch Hall, Germany. Results: According to the Kaplan–Meier survival analysis, the estimated overall 3-year survival rate was 91.1% for women and 88.9% for men. The log-rank test of equality of survival distributions indicateda st","cbCaitorzI7omqRH","https://ap.wps.com/l/cbCaitorzI7omqRH","pdf",829821,11,"English","# Simple Summary\n# Abstract\n# Keywords\n# 1. Introduction\n## Epidemiology and global burden\n## Treatment approach and clinical differences\n## Risk and prognostic factors\n## Role of diagnosis and medical imaging\n# 2. Material and Method\n## Study design and data source\n## Study population and time frame\n# 3. Results\n## Kaplan–Meier survival estimates\n## Log-rank test and age-matched analysis\n# 4. Conclusions","[{\"question\":\"What is the study’s main objective?\",\"answer\":\"To compare survival outcomes between male and female breast cancer patients and assess differences in overall survival.\"},{\"question\":\"How many patients were included, and what years were covered?\",\"answer\":\"The study included 2162 cases (19 males and 2143 females) registered from 1 January 2010 to 31 December 2021.\"},{\"question\":\"What did the Kaplan–Meier analysis show for 3-year overall survival?\",\"answer\":\"The estimated 3-year overall survival was 91.1% for women and 88.9% for men.\"},{\"question\":\"Were survival differences statistically significant?\",\"answer\":\"Yes. The log-rank test indicated a statistically significant difference in survival times between the groups (p=0.009), while the age-matched analysis yielded p=0.068.\"}]","Observational Study of Men and Women with Breast Cancer in Terms of Overall Survival - Research Findings Summary | PDF",1790044063,28,[151,155,159,163],{"page_no":22,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/49855aa104d1627e69ca2d58da765d0c.webp",983,1390,{"page_no":26,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79798601bb1c56edbec46979fe552d75.webp",982,1388,{"page_no":30,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d04e04791ea1f2577f00c945d8df0c8b.webp",981,1387,{"page_no":33,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e680cf28ba1980e787e0f727e2a4908.webp",980,1385]